{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:23:14Z","timestamp":1787613794944,"version":"build-2736575974"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pneumonia"],"DOI":"10.1186\/s41479-026-00209-y","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:03:16Z","timestamp":1787612596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A clinician\u2019s guide to corticosteroid therapy in pneumonia and critical illness: agent selection, dosing, monitoring, and interactions"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6700-3570","authenticated-orcid":false,"given":"Niloofar","family":"Khoshnam Rad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayebeh","family":"Lakzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nakhostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9533-0103","authenticated-orcid":false,"given":"Sara","family":"Soltanmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"8","key":"209_CR1","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","volume":"23","author":"L Cronin","year":"1995","unstructured":"Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis. Crit Care Med. 1995;23(8):1430\u20139. https:\/\/doi.org\/10.1097\/00003246-199508000-00019.","journal-title":"Crit Care Med"},{"issue":"7","key":"209_CR2","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1097\/00003246-199507000-00021","volume":"23","author":"R Lefering","year":"1995","unstructured":"Lefering R, Neugebauer EAM. Steroid controversy in sepsis and septic shock. Crit Care Med. 1995;23(7):1294\u2013303. https:\/\/doi.org\/10.1097\/00003246-199507000-00021.","journal-title":"Crit Care Med"},{"key":"209_CR3","doi-asserted-by":"publisher","unstructured":"Sobolewska J, Dzialach L, Kuca P, Witek P. Critical illness-related corticosteroid insufficiency (CIRCI) - an overview of pathogenesis, clinical presentation and management. Front Endocrinol (Lausanne). 2024;15. https:\/\/doi.org\/10.3389\/fendo.2024.1473151.","DOI":"10.3389\/fendo.2024.1473151"},{"issue":"1","key":"209_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1378\/chest.08-1149","volume":"135","author":"PE Marik","year":"2009","unstructured":"Marik PE. Critical Illness-Related Corticosteroid Insufficiency. Chest. 2009;135(1):181\u201393. https:\/\/doi.org\/10.1378\/chest.08-1149.","journal-title":"Chest"},{"issue":"6","key":"209_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/0885066607307832","volume":"22","author":"MS Cooper","year":"2007","unstructured":"Cooper MS, Stewart PM. Adrenal Insufficiency in Critical Illness. J Intensive Care Med. 2007;22(6):348\u201362. https:\/\/doi.org\/10.1177\/0885066607307832.","journal-title":"J Intensive Care Med"},{"issue":"7","key":"209_CR6","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"D Annane","year":"2002","unstructured":"Annane D. Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock. JAMA. 2002;288(7):862. https:\/\/doi.org\/10.1001\/jama.288.7.862.","journal-title":"JAMA"},{"issue":"5","key":"209_CR7","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","volume":"52","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Nei AM, Rochwerg B, et al. 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia. Crit Care Med. 2024;52(5):e219\u201333. https:\/\/doi.org\/10.1097\/CCM.0000000000006172.","journal-title":"Crit Care Med"},{"issue":"21","key":"209_CR8","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"P-F Dequin","year":"2023","unstructured":"Dequin P-F, Meziani F, Quenot J-P, et al. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med. 2023;388(21):1931\u201341. https:\/\/doi.org\/10.1056\/NEJMoa2215145.","journal-title":"N Engl J Med"},{"issue":"8","key":"209_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/nejmoa2021436","volume":"384","author":"RECOVERY Collaborative Group","year":"2021","unstructured":"RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704. https:\/\/doi.org\/10.1056\/nejmoa2021436.","journal-title":"N Engl J Med"},{"issue":"3","key":"209_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar J, Ferrando C, Mart\u00ednez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267\u201376. https:\/\/doi.org\/10.1016\/S2213-2600(19)30417-5.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"209_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med. 2018;378(9):809\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1705716.","journal-title":"N Engl J Med"},{"issue":"9","key":"209_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med. 2018;378(9):797\u2013808. https:\/\/doi.org\/10.1056\/NEJMoa1705835.","journal-title":"N Engl J Med"},{"issue":"4","key":"209_CR13","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1097\/CCE.0000000000001071","volume":"6","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Israelian L, Putowski Z, et al. Adverse Effects Related to Corticosteroid Use in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis. Crit Care Explor. 2024;6(4):e1071. https:\/\/doi.org\/10.1097\/CCE.0000000000001071.","journal-title":"Crit Care Explor"},{"issue":"7","key":"209_CR14","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4\u20135","key":"209_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.36290\/aim.2021.057","volume":"32","author":"D Astapenko","year":"2021","unstructured":"Astapenko D, \u010cern\u00fd V. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2021. Anesteziol Intenziv medic\u00edna. 2021;32(4\u20135):249\u201355. https:\/\/doi.org\/10.36290\/aim.2021.057.","journal-title":"Anesteziol Intenziv medic\u00edna"},{"issue":"21","key":"209_CR16","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1056\/NEJM200305223482123","volume":"348","author":"M Cooper","year":"2003","unstructured":"Cooper M, Stewart P. Corticosteroid Insufficiency in Acutely Ill Patients. N Engl J Med. 2003;348(21):2157\u20139. https:\/\/doi.org\/10.1056\/NEJM200305223482123.","journal-title":"N Engl J Med"},{"issue":"12","key":"209_CR17","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1097\/CCM.0000000000002737","volume":"45","author":"D Annane","year":"2017","unstructured":"Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2017;45(12):2078\u201388. https:\/\/doi.org\/10.1097\/CCM.0000000000002737.","journal-title":"Crit Care Med"},{"issue":"3","key":"209_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00132586-199906000-00015","volume":"43","author":"GU Meduri","year":"1999","unstructured":"Meduri GU, Headley A, Golden E, Al E. Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress Syndrome: a Randomized Controlled Trial. Surv Anesthesiol. 1999;43(3):135\u20136. https:\/\/doi.org\/10.1097\/00132586-199906000-00015.","journal-title":"Surv Anesthesiol"},{"issue":"8","key":"209_CR19","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1001\/jama.283.8.1038","volume":"283","author":"D Annane","year":"2000","unstructured":"Annane D. A 3-Level Prognostic Classification in Septic Shock Based on Cortisol Levels and Cortisol Response to Corticotropin. JAMA. 2000;283(8):1038. https:\/\/doi.org\/10.1001\/jama.283.8.1038.","journal-title":"JAMA"},{"issue":"3","key":"209_CR20","doi-asserted-by":"publisher","first-page":"541e","DOI":"10.1016\/j.jcrc.2010.03.004","volume":"25","author":"JIF Salluh","year":"2010","unstructured":"Salluh JIF, Shinotsuka CR, Soares M, et al. Cortisol levels and adrenal response in severe community-acquired pneumonia: A systematic review of the literature. J Crit Care. 2010;25(3):541e. 1-541.e8.","journal-title":"J Crit Care"},{"issue":"2","key":"209_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1183\/09031936.06.00125404","volume":"27","author":"PJ Barnes","year":"2006","unstructured":"Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J. 2006;27(2):413\u201326. https:\/\/doi.org\/10.1183\/09031936.06.00125404.","journal-title":"Eur Respir J"},{"issue":"4","key":"209_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/cc2878","volume":"8","author":"H Prigent","year":"2004","unstructured":"Prigent H, Maxime V, Annane D. Science review: Mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care. 2004;8(4):243. https:\/\/doi.org\/10.1186\/cc2878.","journal-title":"Crit Care"},{"issue":"1","key":"209_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s10020-025-01074-z","volume":"31","author":"SF Mehdi","year":"2025","unstructured":"Mehdi SF, Qureshi MH, Pervaiz S, et al. Endocrine and metabolic alterations in response to systemic inflammation and sepsis: a review article. Mol Med. 2025;31(1):16. https:\/\/doi.org\/10.1186\/s10020-025-01074-z.","journal-title":"Mol Med"},{"key":"209_CR24","doi-asserted-by":"publisher","unstructured":"Kanczkowski W, Sue M, Bornstein SR. Adrenal Gland Microenvironment and Its Involvement in the Regulation of Stress-Induced Hormone Secretion during Sepsis. Front Endocrinol (Lausanne). 2016;7(DEC). https:\/\/doi.org\/10.3389\/fendo.2016.00156.","DOI":"10.3389\/fendo.2016.00156"},{"issue":"20","key":"209_CR25","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.3390\/diagnostics15202588","volume":"15","author":"F Alshamsi","year":"2025","unstructured":"Alshamsi F, Alkaabi S, Alfadli MNM, Alshkeili NANS, Alhosani SMI, Agha A. Cortisol Testing in Septic Shock: An Evaluation of Diagnostic Performance and Predictors of Corticosteroid Use in a Middle Eastern Cohort. Diagnostics. 2025;15(20):2588. https:\/\/doi.org\/10.3390\/diagnostics15202588.","journal-title":"Diagnostics"},{"key":"209_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/s0734-3299(08)70553-7","volume":"2008","author":"SL Zanotti-Cavazzoni","year":"2008","unstructured":"Zanotti-Cavazzoni SL. Adrenal function in sepsis: The retrospective Corticus cohort study. Yearb Crit Care Med. 2008;2008:170\u20131. https:\/\/doi.org\/10.1016\/s0734-3299(08)70553-7.","journal-title":"Yearb Crit Care Med"},{"key":"209_CR27","doi-asserted-by":"publisher","unstructured":"Hao D, Wang Q, Ito M, et al. The ACTH test fails to diagnose adrenal insufficiency and augments cytokine production in sepsis. JCI Insight. 2025;10(8). https:\/\/doi.org\/10.1172\/jci.insight.187487.","DOI":"10.1172\/jci.insight.187487"},{"issue":"4","key":"209_CR28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00134-025-07861-w","volume":"51","author":"N Heming","year":"2025","unstructured":"Heming N, Berry L, Lorenzi E, et al. Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia. Intensive Care Med. 2025;51(4):665\u201380. https:\/\/doi.org\/10.1007\/s00134-025-07861-w.","journal-title":"Intensive Care Med"},{"issue":"6","key":"209_CR29","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B, et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. 2023;49(6):615\u201332. https:\/\/doi.org\/10.1007\/s00134-023-07033-8.","journal-title":"Intensive Care Med"},{"issue":"Suppl 3","key":"209_CR30","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","volume":"64","author":"WS Lim","year":"2009","unstructured":"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1\u201355. https:\/\/doi.org\/10.1136\/thx.2009.121434.","journal-title":"Thorax"},{"key":"209_CR31","doi-asserted-by":"publisher","unstructured":"Cao L, Xiang Y, Wu Z, et al. Efficacy and safety of corticosteroids in critically ill patients: a systematic review and meta-analysis. BMC Anesthesiol. 2025;25(1). https:\/\/doi.org\/10.1186\/s12871-025-03196-7.","DOI":"10.1186\/s12871-025-03196-7"},{"issue":"1","key":"209_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41479-025-00195-7","volume":"18","author":"F Carpenteri","year":"2026","unstructured":"Carpenteri F, Cilloniz C, Torres A. Corticosteroids in severe community-acquired pneumonia: friend, foe or both? Pneumonia. 2026;18(1):5. https:\/\/doi.org\/10.1186\/s41479-025-00195-7.","journal-title":"Pneumonia"},{"issue":"5","key":"209_CR33","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s10787-023-01251-8","volume":"31","author":"CS Kow","year":"2023","unstructured":"Kow CS, Ramachandram DS, Hasan SS. Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials. Inflammopharmacology. 2023;31(5):2773\u20139. https:\/\/doi.org\/10.1007\/s10787-023-01251-8.","journal-title":"Inflammopharmacology"},{"issue":"6","key":"209_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jinf.2023.09.008","volume":"87","author":"TAC Snow","year":"2023","unstructured":"Snow TAC, Arulkumaran N, Singer M, Choi SH. Effect of dexamethasone dose on outcomes in acute COVID-19 disease: A systematic review and meta-analysis. J Infect. 2023;87(6):490\u20137. https:\/\/doi.org\/10.1016\/j.jinf.2023.09.008.","journal-title":"J Infect"},{"issue":"2","key":"209_CR35","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1097\/CCM.0000000000004093","volume":"48","author":"LE Lansbury","year":"2020","unstructured":"Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Shen Lim W. Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis. Crit Care Med. 2020;48(2):e98\u2013106. https:\/\/doi.org\/10.1097\/CCM.0000000000004093.","journal-title":"Crit Care Med"},{"issue":"1","key":"209_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13054-019-2395-8","volume":"23","author":"Y-N Ni","year":"2019","unstructured":"Ni Y-N, Chen G, Sun J, Liang B-M, Liang Z-A. The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Crit Care. 2019;23(1):99. https:\/\/doi.org\/10.1186\/s13054-019-2395-8.","journal-title":"Crit Care"},{"issue":"9","key":"209_CR37","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s00134-018-5332-4","volume":"44","author":"G Moreno","year":"2018","unstructured":"Moreno G, Rodr\u00edguez A, Reyes LF, et al. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Med. 2018;44(9):1470\u201382. https:\/\/doi.org\/10.1007\/s00134-018-5332-4.","journal-title":"Intensive Care Med"},{"issue":"12","key":"209_CR38","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1007\/s00134-020-06289-8","volume":"46","author":"GU Meduri","year":"2020","unstructured":"Meduri GU, Annane D, Confalonieri M, et al. Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS. Intensive Care Med. 2020;46(12):2284\u201396. https:\/\/doi.org\/10.1007\/s00134-020-06289-8.","journal-title":"Intensive Care Med"},{"issue":"4","key":"209_CR39","doi-asserted-by":"publisher","first-page":"100207","DOI":"10.1016\/j.chstcc.2025.100207","volume":"3","author":"R Imai","year":"2025","unstructured":"Imai R, Niitsu T, Liu MY, Faust H, Schnapp LM, Yamamoto S. Comparison of Corticosteroid Regimens for COVID-19 and Non-COVID-19 ARDS. CHEST Crit Care. 2025;3(4):100207. https:\/\/doi.org\/10.1016\/j.chstcc.2025.100207.","journal-title":"CHEST Crit Care"},{"issue":"19","key":"209_CR40","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.2174\/138161206777698981","volume":"12","author":"CC Villar","year":"2006","unstructured":"Villar CC, Dongari-Bagtzoglou A. Therapeutic modulation of cytokines in chronic infectious diseases. Curr Pharm Des. 2006;12(19):2329\u201348. https:\/\/doi.org\/10.2174\/138161206777698981.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"209_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung CL, Annane D, Keh D, et al. Hydrocortisone Therapy for Patients with Septic Shock. N Engl J Med. 2008;358(2):111\u201324. https:\/\/doi.org\/10.1056\/NEJMoa071366.","journal-title":"N Engl J Med"},{"issue":"5","key":"209_CR42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock. JAMA. 2016;316(5):509. https:\/\/doi.org\/10.1001\/jama.2016.10485.","journal-title":"JAMA"},{"issue":"12","key":"209_CR43","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1007\/s00134-024-07616-z","volume":"50","author":"J Walsham","year":"2024","unstructured":"Walsham J, Hammond N, Blumenthal A, et al. Fludrocortisone dose\u2013response relationship in septic shock: a randomised phase II trial. Intensive Care Med. 2024;50(12):2050\u201360. https:\/\/doi.org\/10.1007\/s00134-024-07616-z.","journal-title":"Intensive Care Med"},{"issue":"1","key":"209_CR44","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/cc10601","volume":"16","author":"HY Park","year":"2012","unstructured":"Park HY, Suh GY, Song J-U, et al. Early initiation of low-dose corticosteroid therapy in the management of septic shock: a retrospective observational study. Crit Care. 2012;16(1):R3. https:\/\/doi.org\/10.1186\/cc10601.","journal-title":"Crit Care"},{"issue":"2","key":"209_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/0018578719829416","volume":"55","author":"J Yerke","year":"2020","unstructured":"Yerke J, Strnad K, Bauer SR. Corticosteroids for Septic Shock: Another Chapter in the Saga. Hosp Pharm. 2020;55(2):135\u201342. https:\/\/doi.org\/10.1177\/0018578719829416.","journal-title":"Hosp Pharm"},{"key":"209_CR46","doi-asserted-by":"publisher","unstructured":"Zhou Y, Fu X, Liu X, et al. Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis. Sci Rep. 2020;10(1). https:\/\/doi.org\/10.1038\/s41598-020-59732-7.","DOI":"10.1038\/s41598-020-59732-7"},{"issue":"1","key":"209_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41479-026-00202-5","volume":"18","author":"JA Morales-Olivera","year":"2026","unstructured":"Morales-Olivera JA, Narvaez-Ramirez PO, Bustos IG, et al. Corticosteroids in immunocompromised ICU patients with pneumonia: risks, evidence, and clinical practice. Pneumonia. 2026;18(1):12. https:\/\/doi.org\/10.1186\/s41479-026-00202-5.","journal-title":"Pneumonia"},{"issue":"4","key":"209_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4):233\u201347. https:\/\/doi.org\/10.1038\/nri.2017.1.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"209_CR49","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1097\/CCM.0000000000002724","volume":"45","author":"D Annane","year":"2017","unstructured":"Annane D, Pastores SM, Arlt W, et al. Critical Illness-Related Corticosteroid Insufficiency (CIRCI): A narrative review from a multispecialty task force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM). Crit Care Med. 2017;45(12):2089\u201398. https:\/\/doi.org\/10.1097\/CCM.0000000000002724.","journal-title":"Crit Care Med"},{"issue":"9","key":"209_CR50","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S2213-2600(25)00125-0","volume":"13","author":"V Lemiale","year":"2025","unstructured":"Lemiale V, Resche-Rigon M, Zerbib Y, et al. Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med. 2025;13(9):800\u20138. https:\/\/doi.org\/10.1016\/S2213-2600(25)00125-0.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"209_CR51","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S2213-2600(25)00197-3","volume":"13","author":"L Shapiro","year":"2025","unstructured":"Shapiro L, Henao-Mart\u00ednez AF. Adjunct corticosteroids for non-HIV infected patients with severe Pneumocystis jirovecii pneumonia. Lancet Respir Med. 2025;13(9):771\u20133. https:\/\/doi.org\/10.1016\/S2213-2600(25)00197-3.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"209_CR52","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/10600280211021103","volume":"56","author":"D Ragoonanan","year":"2022","unstructured":"Ragoonanan D, Allen B, Cannon C, Rottman-Pietrzak K, Bello A. Comparison of Early Versus Late Initiation of Hydrocortisone in Patients With Septic Shock in the ICU Setting. Ann Pharmacother. 2022;56(3):264\u201370. https:\/\/doi.org\/10.1177\/10600280211021103.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"209_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/bcp.12295","volume":"78","author":"SMC Spoorenberg","year":"2014","unstructured":"Spoorenberg SMC, Deneer VHM, Grutters JC, et al. Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. Br J Clin Pharmacol. 2014;78(1):78\u201383. https:\/\/doi.org\/10.1111\/bcp.12295.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"209_CR54","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bjae.2018.01.005","volume":"18","author":"A Young","year":"2018","unstructured":"Young A, Marsh S. Steroid use in critical care. BJA Educ. 2018;18(5):129\u201334. https:\/\/doi.org\/10.1016\/j.bjae.2018.01.005.","journal-title":"BJA Educ"},{"issue":"4","key":"209_CR55","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/00912700122010276","volume":"41","author":"CR Yates","year":"2001","unstructured":"Yates CR, Vysokanov A, Mukherjee A, et al. Time-Variant Increase in Methylprednisolone Clearance in Patients with Acute Respiratory Distress Syndrome: A Population Pharmacokinetic Study. J Clin Pharmacol. 2001;41(4):415\u201324. https:\/\/doi.org\/10.1177\/00912700122010276.","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"209_CR56","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/s41366-022-01204-1","volume":"46","author":"E Wittermans","year":"2022","unstructured":"Wittermans E, Grutters JC, Moeniralam HS, et al. Overweight and obesity are not associated with worse clinical outcomes in COVID-19 patients treated with fixed-dose 6\u00a0mg dexamethasone. Int J Obes. 2022;46(11):2000\u20135. https:\/\/doi.org\/10.1038\/s41366-022-01204-1.","journal-title":"Int J Obes"},{"issue":"7","key":"209_CR57","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1111\/cts.13297","volume":"15","author":"K Abouir","year":"2022","unstructured":"Abouir K, Gosselin P, Guerrier S, et al. Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trial. Clin Transl Sci. 2022;15(7):1796\u2013804. https:\/\/doi.org\/10.1111\/cts.13297.","journal-title":"Clin Transl Sci"},{"issue":"4","key":"209_CR58","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.therap.2018.11.016","volume":"74","author":"J Delaleu","year":"2019","unstructured":"Delaleu J, Destere A, Hachon L, Decl\u00e8ves X, Lloret-Linares C. Glucocorticoids dosing in obese subjects: A systematic review. Therapies. 2019;74(4):451\u20138. https:\/\/doi.org\/10.1016\/j.therap.2018.11.016.","journal-title":"Therapies"},{"issue":"1","key":"209_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s44158-025-00335-x","volume":"6","author":"PS Mahmoudi","year":"2026","unstructured":"Mahmoudi PS, Sadeghi F, Saberian M, Khalili H, Shafaati M. Continuous vs. intermittent infusion of corticosteroids in septic shock: a GRADE-based systematic review and meta-analysis. J Anesth Analg Crit Care. 2026;6(1):16. https:\/\/doi.org\/10.1186\/s44158-025-00335-x.","journal-title":"J Anesth Analg Crit Care"},{"key":"209_CR60","doi-asserted-by":"publisher","unstructured":"Jin L, Li Z, Qian J, Liao W, Xu F. Comparative efficacy and prognostic impact of continuous versus intermittent hydrocortisone administration in septic shock patients. Sci Rep. 2025;15(1). https:\/\/doi.org\/10.1038\/s41598-025-99198-z.","DOI":"10.1038\/s41598-025-99198-z"},{"issue":"9203","key":"209_CR61","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/S0140-6736(99)06290-X","volume":"355","author":"C Henzen","year":"2000","unstructured":"Henzen C, Suter A, Lerch E, Urbinelli R, Schorno XH, Briner VA. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet. 2000;355(9203):542\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(99)06290-X.","journal-title":"Lancet"},{"issue":"5","key":"209_CR62","doi-asserted-by":"publisher","first-page":"G25","DOI":"10.1093\/ejendo\/lvae029","volume":"190","author":"F Beuschlein","year":"2024","unstructured":"Beuschlein F, Else T, Bancos I, et al. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. Eur J Endocrinol. 2024;190(5):G25\u201351. https:\/\/doi.org\/10.1093\/ejendo\/lvae029.","journal-title":"Eur J Endocrinol"},{"key":"209_CR63","doi-asserted-by":"publisher","unstructured":"Prete A, Bancos I. Glucocorticoid induced adrenal insufficiency. BMJ July. 2021;n1380. https:\/\/doi.org\/10.1136\/bmj.n1380.","DOI":"10.1136\/bmj.n1380"},{"issue":"7","key":"209_CR64","doi-asserted-by":"publisher","first-page":"e1290","DOI":"10.1097\/CCE.0000000000001290","volume":"7","author":"HO AlMubayedh","year":"2025","unstructured":"AlMubayedh HO, AlMehizia RA, Salam A, et al. Evaluation of Hydrocortisone Discontinuation Strategies in Septic Shock: A Retrospective Cohort Study. Crit Care Explor. 2025;7(7):e1290. https:\/\/doi.org\/10.1097\/CCE.0000000000001290.","journal-title":"Crit Care Explor"},{"issue":"11","key":"209_CR65","doi-asserted-by":"publisher","first-page":"e2031","DOI":"10.1210\/clinem\/dgae059","volume":"109","author":"MF Arshad","year":"2024","unstructured":"Arshad MF, Elder C, Newell-Price J, Ross R, Debono M. A Retrospective Study on Weaning Glucocorticoids and Recovery of the Hypothalamic\u2013Pituitary\u2013Adrenal Axis. J Clin Endocrinol Metab. 2024;109(11):e2031\u20137. https:\/\/doi.org\/10.1210\/clinem\/dgae059.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"209_CR66","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1210\/jc.2008-0710","volume":"93","author":"R Kazlauskaite","year":"2008","unstructured":"Kazlauskaite R, Evans AT, Villabona CV, et al. Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: A metaanalysis. J Clin Endocrinol Metab. 2008;93(11):4245\u201353. https:\/\/doi.org\/10.1210\/jc.2008-0710.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"209_CR67","doi-asserted-by":"publisher","first-page":"116","DOI":"10.18773\/austprescr.2025.037","volume":"48","author":"F Khalili","year":"2025","unstructured":"Khalili F, Burt MG. Practical guidance for stopping glucocorticoids. Aust Prescr. 2025;48(4):116\u201321. https:\/\/doi.org\/10.18773\/austprescr.2025.037.","journal-title":"Aust Prescr"},{"issue":"2","key":"209_CR68","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","volume":"63","author":"AW Meikle","year":"1977","unstructured":"Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Am J Med. 1977;63(2):200\u20137. https:\/\/doi.org\/10.1016\/0002-9343(77)90233-9.","journal-title":"Am J Med"},{"issue":"3","key":"209_CR69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/MED.0000000000000804","volume":"30","author":"V Theiler-Schwetz","year":"2023","unstructured":"Theiler-Schwetz V, Prete A. Glucocorticoid withdrawal syndrome: what to expect and how to manage. Curr Opin Endocrinol Diabetes Obes. 2023;30(3):167\u201374. https:\/\/doi.org\/10.1097\/MED.0000000000000804.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"209_CR70","doi-asserted-by":"publisher","first-page":"488","DOI":"10.20945\/2359-3997000000392","volume":"65","author":"LM Lousada","year":"2021","unstructured":"Lousada LM, Mendonca BB, Bachega TASS. Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia. Arch Endocrinol Metab. 2021;65(4):488\u201394. https:\/\/doi.org\/10.20945\/2359-3997000000392.","journal-title":"Arch Endocrinol Metab"},{"issue":"2","key":"209_CR71","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364\u201389. https:\/\/doi.org\/10.1210\/jc.2015-1710.","journal-title":"J Clin Endocrinol Metab"},{"key":"209_CR72","doi-asserted-by":"publisher","unstructured":"Chen AXN, Radhakutty A, Thompson C, Burt MG. Performance of an individualized, subcutaneous, basal-bolus insulin regimen for the management of prednisolone-associated hyperglycemia in hospitalized patients: a proof-of-concept study. BMJ Open Diabetes Res Care. 2025;13(6). https:\/\/doi.org\/10.1136\/bmjdrc-2025-004963.","DOI":"10.1136\/bmjdrc-2025-004963"},{"issue":"7","key":"209_CR73","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/phar.2944","volume":"44","author":"BJ Haan","year":"2024","unstructured":"Haan BJ, Blackmon SN, Cobb AM, et al. Corticosteroids in critically ill patients: A narrative review. Pharmacotherapy. 2024;44(7):581\u2013602. https:\/\/doi.org\/10.1002\/phar.2944.","journal-title":"Pharmacotherapy"},{"issue":"Supplement1","key":"209_CR74","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.2337\/dc26-S016","volume":"49","author":"M Bajaj","year":"2026","unstructured":"Bajaj M, McCoy RG, Balapattabi K, et al. 16. Diabetes Care in the Hospital: Standards of Care in Diabetes\u20142026. Diabetes Care. 2026;49(Supplement1):S339\u201355. https:\/\/doi.org\/10.2337\/dc26-S016.","journal-title":"Diabetes Care"},{"key":"209_CR75","doi-asserted-by":"publisher","unstructured":"Bansal V, Jain NK, Lal A, et al. The association between early corticosteroid use and the risk of secondary infections in hospitalized patients with COVID-19: a double-edged sword. Results from the international SCCM discovery viral infection and respiratory illness universal study (VIRU. Front Med. 2025;12. https:\/\/doi.org\/10.3389\/fmed.2025.1466346.","DOI":"10.3389\/fmed.2025.1466346"},{"key":"209_CR76","doi-asserted-by":"publisher","first-page":"103940","DOI":"10.1016\/j.iccn.2025.103940","volume":"88","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Hu Q, Zhou M, et al. Risk factors for acquired weakness in intensive care unit patients: An umbrella review. Intensive Crit Care Nurs. 2025;88:103940. https:\/\/doi.org\/10.1016\/j.iccn.2025.103940.","journal-title":"Intensive Crit Care Nurs"},{"key":"209_CR77","doi-asserted-by":"publisher","first-page":"155074","DOI":"10.1016\/j.jcrc.2025.155074","volume":"88","author":"A Huang","year":"2025","unstructured":"Huang A, Salazar M, Weber H, et al. ICU-acquired weakness: Critical illness myopathy and polyneuropathy. J Crit Care. 2025;88:155074. https:\/\/doi.org\/10.1016\/j.jcrc.2025.155074.","journal-title":"J Crit Care"},{"issue":"15","key":"209_CR78","doi-asserted-by":"publisher","first-page":"7616","DOI":"10.3390\/ijms26157616","volume":"26","author":"U Permpoon","year":"2025","unstructured":"Permpoon U, Moon J, Kim CY, Nam T. Glucocorticoid-Mediated Skeletal Muscle Atrophy: Molecular Mechanisms and Potential Therapeutic Targets. Int J Mol Sci. 2025;26(15):7616. https:\/\/doi.org\/10.3390\/ijms26157616.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"209_CR79","doi-asserted-by":"publisher","first-page":"e421","DOI":"10.1097\/CCM.0000000000006330","volume":"52","author":"R MacLaren","year":"2024","unstructured":"MacLaren R, Dionne JC, Granholm A, et al. Society of Critical Care Medicine and American Society of Health-System Pharmacists Guideline for the Prevention of Stress-Related Gastrointestinal Bleeding in Critically Ill Adults. Crit Care Med. 2024;52(8):e421\u201330. https:\/\/doi.org\/10.1097\/CCM.0000000000006330.","journal-title":"Crit Care Med"},{"issue":"1","key":"209_CR80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","volume":"44","author":"D Czock","year":"2005","unstructured":"Czock D, Keller F, Rasche FM, H\u00e4ussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61\u201398. https:\/\/doi.org\/10.2165\/00003088-200544010-00003.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"209_CR81","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0022-3565(25)12795-X","volume":"277","author":"DM Gentile","year":"1996","unstructured":"Gentile DM, Tomlinson ES, Maggs JL, Park BK, Back DJ. Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation. J Pharmacol Exp Ther. 1996;277(1):105\u201312. https:\/\/doi.org\/10.1016\/S0022-3565(25)12795-X.","journal-title":"J Pharmacol Exp Ther"},{"issue":"22","key":"209_CR82","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.3390\/jcm12227120","volume":"12","author":"V Bourdin","year":"2023","unstructured":"Bourdin V, Bigot W, Vanjak A, et al. Drug\u2013Drug Interactions Involving Dexamethasone in Clinical Practice: Myth or Reality? J Clin Med. 2023;12(22):7120. https:\/\/doi.org\/10.3390\/jcm12227120.","journal-title":"J Clin Med"},{"issue":"10","key":"209_CR83","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1086\/598327","volume":"48","author":"RJM Br\u00fcggemann","year":"2009","unstructured":"Br\u00fcggemann RJM, Alffenaar JC, Blijlevens NMA, et al. Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents. Clin Infect Dis. 2009;48(10):1441\u201358. https:\/\/doi.org\/10.1086\/598327.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"209_CR84","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0091-6749(99)70175-2","volume":"103","author":"DA Fost","year":"1999","unstructured":"Fost DA, Leung DYM, Martin RJ, Brown EE, Szefler SJ, Spahn JD. Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. J Allergy Clin Immunol. 1999;103(6):1031\u20135. https:\/\/doi.org\/10.1016\/S0091-6749(99)70175-2.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"209_CR85","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2165\/00003088-199223020-00004","volume":"23","author":"P Periti","year":"1992","unstructured":"Periti P, Mazzei T, Mini E, Novelli A. Pharmacokinetic Drug Interactions of Macrolides. Clin Pharmacokinet. 1992;23(2):106\u201331. https:\/\/doi.org\/10.2165\/00003088-199223020-00004.","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"209_CR86","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1159\/000530701","volume":"113","author":"M Castle-Kirszbaum","year":"2023","unstructured":"Castle-Kirszbaum M, Goldschlager T, Shi MDY, Fuller PJ. Glucocorticoids and Water Balance: Implications for Hyponatremia Management and Pituitary Surgery. Neuroendocrinology. 2023;113(8):785\u201394. https:\/\/doi.org\/10.1159\/000530701.","journal-title":"Neuroendocrinology"},{"key":"209_CR87","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jclinepi.2018.02.008","volume":"98","author":"R Brignardello-Petersen","year":"2018","unstructured":"Brignardello-Petersen R, Johnston BC, Jadad AR, Tomlinson G. Using decision thresholds for ranking treatments in network meta-analysis results in more informative rankings. J Clin Epidemiol. 2018;98:62\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2018.02.008.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"209_CR88","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12890-025-03679-w","volume":"25","author":"L Zhu","year":"2025","unstructured":"Zhu L, Zeng J, Li H, Li K, Chen X. Comparative effect of different corticosteroids in severe community-acquired pneumonia: a network meta-analysis. BMC Pulm Med. 2025;25(1):210. https:\/\/doi.org\/10.1186\/s12890-025-03679-w.","journal-title":"BMC Pulm Med"},{"issue":"36","key":"209_CR89","doi-asserted-by":"publisher","first-page":"e34738","DOI":"10.1097\/MD.0000000000034738","volume":"102","author":"Z Li","year":"2023","unstructured":"Li Z, Xue Y, Li L, Li C. Methylprednisolone or dexamethasone? How should we choose to respond to COVID-19? A systematic review and meta-analysis of randomized controlled trials. Med (Baltim). 2023;102(36):e34738. https:\/\/doi.org\/10.1097\/MD.0000000000034738.","journal-title":"Med (Baltim)"},{"key":"209_CR90","doi-asserted-by":"publisher","unstructured":"Corral-Gudino L, Cusacovich I, Mart\u00edn\u2010Gonz\u00e1lez JI, et al. Effect of intravenous pulses of methylprednisolone 250\u00a0mg versus dexamethasone 6\u00a0mg in hospitalised adults with severe COVID\u201019 pneumonia: An open\u2010label randomised trial. Eur J Clin Invest. 2023;53(1). https:\/\/doi.org\/10.1111\/eci.13881.","DOI":"10.1111\/eci.13881"},{"issue":"10","key":"209_CR91","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1164\/rccm.202310-1785OC","volume":"209","author":"B Teja","year":"2024","unstructured":"Teja B, Berube M, Pereira TV, et al. Effectiveness of Fludrocortisone Plus Hydrocortisone versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Am J Respir Crit Care Med. 2024;209(10):1219\u201328. https:\/\/doi.org\/10.1164\/rccm.202310-1785OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"209_CR92","doi-asserted-by":"publisher","unstructured":"Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for treating sepsis in children and adults. Cochrane Database Syst Rev. 2019;2019(12). https:\/\/doi.org\/10.1002\/14651858.CD002243.pub4.","DOI":"10.1002\/14651858.CD002243.pub4"},{"issue":"1","key":"209_CR93","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12879-025-10731-x","volume":"25","author":"J Xu","year":"2025","unstructured":"Xu J, Cai H, Zheng X. Effect of methylprednisolone vs hydrocortisone on 30-day mortality in critically ill adults with septic shock: an analysis of the MIMIC-IV database. BMC Infect Dis. 2025;25(1):328. https:\/\/doi.org\/10.1186\/s12879-025-10731-x.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"209_CR94","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1136\/thorax-2023-221131","volume":"79","author":"LK Torres","year":"2024","unstructured":"Torres LK, Siempos II. Identifying a hyperinflammatory subphenotype of ARDS associated with worse outcomes: may ferritin help? Thorax. 2024;79(3):200\u20131. https:\/\/doi.org\/10.1136\/thorax-2023-221131.","journal-title":"Thorax"},{"issue":"21","key":"209_CR95","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.3390\/diagnostics13213296","volume":"13","author":"R Ge","year":"2023","unstructured":"Ge R, Wang F, Peng Z. Advances in Biomarkers for Diagnosis and Treatment of ARDS. Diagnostics. 2023;13(21):3296. https:\/\/doi.org\/10.3390\/diagnostics13213296.","journal-title":"Diagnostics"},{"key":"209_CR96","doi-asserted-by":"publisher","unstructured":"\u0160tampar P, Blagus T, Gori\u010dar K, et al. Genetic variability in the glucocorticoid pathway and treatment outcomes in hospitalized patients with COVID-19: a pilot study. Front Pharmacol. 2024;15. https:\/\/doi.org\/10.3389\/fphar.2024.1418567.","DOI":"10.3389\/fphar.2024.1418567"},{"issue":"12","key":"209_CR97","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1038\/s41591-025-03964-5","volume":"31","author":"BP Scicluna","year":"2025","unstructured":"Scicluna BP, Cano-Gamez K, Burnham KL, et al. A consensus blood transcriptomic framework for sepsis. Nat Med. 2025;31(12):4119\u201330. https:\/\/doi.org\/10.1038\/s41591-025-03964-5.","journal-title":"Nat Med"},{"issue":"9","key":"209_CR98","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00134-025-08047-0","volume":"51","author":"MJ Cummings","year":"2025","unstructured":"Cummings MJ, Lutwama JJ, Tomoiaga AS, et al. Identification of transcriptomic sepsis endotypes in sub-Saharan Africa: derivation, validation, and global alignment in two Ugandan cohorts. Intensive Care Med. 2025;51(9):1573\u201386. https:\/\/doi.org\/10.1007\/s00134-025-08047-0.","journal-title":"Intensive Care Med"},{"issue":"1","key":"209_CR99","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jointm.2025.07.002","volume":"6","author":"A Jagesar","year":"2026","unstructured":"Jagesar A, Smalbil L, Galea E, et al. Causal deep learning to personalize medicine: Which intensive care patients with sepsis will benefit from corticosteroid therapy? J Intensive Med. 2026;6(1):61\u20138. https:\/\/doi.org\/10.1016\/j.jointm.2025.07.002.","journal-title":"J Intensive Med"}],"container-title":["Pneumonia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-026-00209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41479-026-00209-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-026-00209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:03:17Z","timestamp":1787612597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41479-026-00209-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["209"],"URL":"https:\/\/doi.org\/10.1186\/s41479-026-00209-y","relation":{},"ISSN":["2200-6133"],"issn-type":[{"value":"2200-6133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"3 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was not required for this Review Article.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate \/ consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors acknowledge the use of the AI language model DeepSeek for text refinement, grammar checks, and improving narrative clarity. The authors reviewed, edited, and take full responsibility for the final content.","order":3,"name":"Ethics","label":"Use of AI statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"19"}}